Page results
-
A major new consortium led by UCLH and UCL has been awarded £6.8 million by the National Institute of Health Research to conduct the largest clinical study of long COVID over the next two years.
-
In May 2020, UCLH invited acclaimed photographer Tom Pilston to take portraits of staff at the height of the Covid-19 pandemic.
-
Two doses of the Oxford-AstraZeneca COVID-19 vaccine induce lower levels of antibodies that are able to recognise and fight the SARS-CoV-2 Delta variant (B.1.617.2) than against other strains, according to laboratory findings from UCLH and the Francis Crick Institute.
-
Researchers at the NIHR UCLH Clinical Research Facility are the first in the world to start a new first-in-human trial investigating a novel treatment, called NVG-111, in patients with Non-Hodgkin lymphoma (NHL) subtypes.
-
People infected with coronavirus have a distinct odour that can be detected by trained dogs with a high degree of accuracy, according to new research involving UCLH.
-
UCLH Director of Research Professor Bryan Williams and Consultant Neuropsychologist at UCLH Professor Lisa Cipolotti have been elected Fellows of the Academy of Medical Sciences in recognition of their exceptional contributions to biomedical and health science.
-
Mild Covid-19 infection is very unlikely to cause lasting damage to the structure or function of the heart, according to a study supported by the NIHR UCLH Biomedical Research Centre and UCLH Charity.
-
UCLH is to lead an initiative to improve care for myeloma patients alongside Oxford University Hospitals NHS Foundation Trust (OUH) and University Hospital Southampton NHS Foundation Trust (UHS).
-
The Com-Cov trial in which UCLH is a site looking at alternating vaccines has been expanded to include the Moderna and Novavax vaccines.
-
A directory of UK organisations which provide specialist support to anyone affected by cancer or a blood condition
File results
-
FOI/2024/0409 - Number of A&E attendees with mental health complaints from 2022 to 2024
-
FOI/2024/0415 - Biologic and targeted medications within dermatology medicine
-
FOI/2024/0417 - Funding for point-of-care home blood monitoring devices for cancer patients
-
FOI/2024/0424 - Ectopic pregnancies
-
FOI/2024/0431 - Hospital patient monitoring system on wards
-
FOI/2024/0444 - Protocols for titanium/ titanium alloy clips to repair ruptured brain aneurysms
-
FOI/2024/0445 - Framework agency spend for locum doctors for February to March 2024
-
FOI/2024/0535 - Agency spend, providers and department contacts for locums by specialities and sites
-
FOI/2024/0537 - SHO doctor shifts covered by physician associates December 2023-May 2024
-
FOI/2024/0554 - Robotic Process Automation (RPA) Programme